Hiromasa Aoki

1.4k total citations
34 papers, 1.1k citations indexed

About

Hiromasa Aoki is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hiromasa Aoki has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Hiromasa Aoki's work include Cancer-related Molecular Pathways (6 papers), Bone Metabolism and Diseases (5 papers) and MicroRNA in disease regulation (3 papers). Hiromasa Aoki is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Bone Metabolism and Diseases (5 papers) and MicroRNA in disease regulation (3 papers). Hiromasa Aoki collaborates with scholars based in Japan. Hiromasa Aoki's co-authors include Mitsuyasu Kato, Kohei Miyazono, Makiko Fujii, Takeshi Imamura, Ken Yagi, T. Kuber Sampath, Masahiro Kawabata, Hidenori Ichijo, Kohsuke Takeda and Shoji ENOMOTO and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Hiromasa Aoki

34 papers receiving 1.1k citations

Peers

Hiromasa Aoki
Krishna M. Sinha United States
Sylke Haßel Germany
Luis F de Castro United States
Nico Smets Belgium
Francesca Soncin United States
Xin‐Zi Chi South Korea
Krishna M. Sinha United States
Hiromasa Aoki
Citations per year, relative to Hiromasa Aoki Hiromasa Aoki (= 1×) peers Krishna M. Sinha

Countries citing papers authored by Hiromasa Aoki

Since Specialization
Citations

This map shows the geographic impact of Hiromasa Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromasa Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromasa Aoki more than expected).

Fields of papers citing papers by Hiromasa Aoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromasa Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromasa Aoki. The network helps show where Hiromasa Aoki may publish in the future.

Co-authorship network of co-authors of Hiromasa Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromasa Aoki. A scholar is included among the top collaborators of Hiromasa Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromasa Aoki. Hiromasa Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inamura, Naoko, Takashi Watanabe, Hiromasa Aoki, et al.. (2024). Promyelinating drugs ameliorate oligodendrocyte pathologies in a mouse model of Krabbe disease. Molecular Genetics and Metabolism. 142(3). 108497–108497. 1 indexed citations
2.
Inoue, Yasumichi, Daisuke Morishita, Hiromasa Aoki, et al.. (2024). ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis. Biochemical and Biophysical Research Communications. 708. 149789–149789. 1 indexed citations
3.
Kakita, Hiroki, Hiromasa Aoki, Yasumichi Inoue, et al.. (2024). Thrombopoietin exerts a neuroprotective effect by inhibiting the suppression of neuronal proliferation and axonal outgrowth in intrauterine growth restriction rats. Experimental Neurology. 377. 114781–114781. 1 indexed citations
4.
Aoki, Hiromasa, Sumitaka Yamanaka, Daisuke Morishita, et al.. (2024). The Hippo Signaling Pathway Manipulates Cellular Senescence. Cells. 14(1). 13–13. 1 indexed citations
5.
Aoki, Hiromasa, Rina Kato, Yasumichi Inoue, et al.. (2023). The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells. Cancers. 15(3). 735–735. 3 indexed citations
6.
Aoki, Hiromasa, Hiroki Kakita, Hiroko Ueda, et al.. (2023). Monocyte-Derived miRNA-1914-5p Attenuates IL-1β–Induced Monocyte Adhesion and Transmigration. International Journal of Molecular Sciences. 24(3). 2829–2829. 5 indexed citations
7.
Aoki, Hiromasa, Yasumichi Inoue, Hidetoshi Hayashi, et al.. (2023). AMPK activators suppress cholesterol accumulation in macrophages via suppression of the mTOR pathway. Experimental Cell Research. 432(1). 113784–113784. 5 indexed citations
8.
Kakita, Hiroki, et al.. (2022). Thrombocytopenia and insufficient thrombopoietin production in human small-for-gestational-age infants. Pediatric Research. 93(3). 619–624. 1 indexed citations
9.
Kondo, Takao, Hiromasa Aoki, Yuko Waguri‐Nagaya, et al.. (2021). The Inducible Nitric Oxide Synthase Pathway Promotes Osteoclastogenesis under Hypoxic Culture Conditions. American Journal Of Pathology. 191(12). 2072–2079. 14 indexed citations
10.
Aoki, Hiromasa, et al.. (2021). Three-dimensional spheroid culture induces apical-basal polarity and the original characteristics of immortalized human renal proximal tubule epithelial cells. Experimental Cell Research. 404(1). 112630–112630. 9 indexed citations
11.
Aoki, Hiromasa, et al.. (2021). Interleukin-1β enhances cell adhesion in human endothelial cells via microRNA-1914–5p suppression. Biochemistry and Biophysics Reports. 27. 101046–101046. 16 indexed citations
12.
Kimura, Yuka, Hiromasa Aoki, Akihiro Nomoto, et al.. (2021). Photodynamic therapy exploiting the anti-tumor activity of mannose-conjugated chlorin e6 reduced M2-like tumor-associated macrophages. Translational Oncology. 14(2). 101005–101005. 26 indexed citations
15.
Aoki, Hiromasa, et al.. (2020). IL-6 promotes cell adhesion in human endothelial cells via microRNA-126–3p suppression. Experimental Cell Research. 393(2). 112094–112094. 20 indexed citations
16.
Aoki, Hiromasa, et al.. (2019). Isolation of induced pluripotent stem cell-derived endothelial progenitor cells from sac-like structures. Biochemical and Biophysical Research Communications. 515(4). 672–678. 3 indexed citations
17.
Okada, Atsushi, Hiromasa Aoki, Taiki Kato, et al.. (2019). Active Phagocytosis and Diachronic Processing of Calcium Oxalate Monohydrate Crystals in an in vitro Macrophage Model. Kidney & Blood Pressure Research. 44(5). 1014–1025. 9 indexed citations
18.
Kasahara, Kousuke, Hiromasa Aoki, Tohru Kiyono, et al.. (2018). EGF receptor kinase suppresses ciliogenesis through activation of USP8 deubiquitinase. Nature Communications. 9(1). 758–758. 58 indexed citations
19.
Yagi, Ken, Masao Furuhashi, Hiromasa Aoki, et al.. (2002). c-myc Is a Downstream Target of the Smad Pathway. Journal of Biological Chemistry. 277(1). 854–861. 204 indexed citations
20.
Takata, Minoru, Akihide Fujimoto, Hiromasa Aoki, et al.. (1999). erbB-2 Overexpression But No Activation of β-Catenin Gene in Extramammary Paget's Disease. Journal of Investigative Dermatology. 113(2). 258–262. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026